Protein Expression Publications

  1. Berrow N. S., Buessow K., Coutard B., Diprose J., Ekberg M., Folkers G. E., Levy N., Lieu V., Owens R. J., Peleg Y., Pinaglia C., Quevillon-Cheruel S., Salim L., Scheich C., Vincentelli R. & Busso D. (2006). Recombinant protein expression and solubility screening in Escherichia coli: A comparative study.  Acta Crystallographica Section D: Biological Crystallography. 2006 Oct , 62 (10):1218-1226.
  2. Romier C., Ben Jelloul M., Albeck S., Buchwald G., Busso D., Celie P. H., Christodoulou E., De Marco V., Van Gerwen S., Knipscheer P., Lebbink J. H., Notenboom V., Poterszman A., Rochel N., Cohen S. X., Unger T., Sussman J. L., Moras D., Sixma T. K. & Perrakis A. (2006). Co-expression of protein complexes in prokaryotic and eukaryotic hosts: Experimental procedures, database tracking and case studies.  Acta Crystallographica Section D: Biological Crystallography. 2006 Oct , 62 (10):1232-1242.
  3. Albeck S., Burstein Y., Dym O., Jacobovitch Y., Levi N., Meged R., Michael Y., Peleg Y., Prilusky J., Schreiber G., Silman I., Unger T. & Sussman J. (2005). Three-dimensional structure determination of proteins related to human health in their functional context at the Israel Structural Proteomics Center (ISPC).  Acta Crystallographica Section D: Biological Crystallography. 2005 Oct , 61 (10):1364-1372.
  4. Albeck S., Burstein Y., Dym O., Jacobovitch Y., Levi N., Meged R., Michael Y., Peleg Y., Prilusky J., Schreiber G., Silman I., Unger T. & Sussman J. (2005). Three-dimensional structure determination of proteins related to human health in their functional context at the Israel Structural Proteomics Center (ISPC).  Acta Crystallographica Section D: Biological Crystallography. 2005 Oct , 61 (10):1364-1372.
  5. Shao H., Revach M., Moshonov S., Tzuman Y., Gazit K., Albeck S., Unger T. & Dikstein R. (2005). Core promoter binding by histone-like TAF complexes.  Molecular and Cellular Biology. 2005 Jan , 25 (1):206-219.
  6. Ganor Y., Besser M., Ben-Zakay N., Unger T. & Levite M. (2003). Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.  Journal of Immunology. 2003 Apr 15 , 170 (8):4362-4372.
  7. Unger T., Oren Z. & Shai Y. (2001). The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: Implication to their mode of action.  Biochemistry. 2001 May 29 , 40 (21):6388-6397.
  8. Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999). Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.  EMBO Journal. 1999 Apr 1 , 18 (7):1805-1814.
  9. Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999). Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.  Oncogene. 1999 May 27 , 18 (21):3205-3212.
  10. Mor F., Boccaccio G. & Unger T. (1998). Expression of autoimmune disease-related antigens by cells of the immune system.  Journal of Neuroscience Research. 1998 Oct 15 , 54 (2):254-262.
  11. Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998). The Mdm2 oncoprotein interacts with the cell fate regulator numb.  Molecular and Cellular Biology. 1998 Jul , 18 (7):3974-3982.
  12. Fiscella M., Zambrano N., Ullrich S. J., Unger T., Lin D., Cho B., Mercer W. E., Anderson C. W. & Appella E. (1994). The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.  Oncogene. 1994 Nov , 9 (11):3249-57.
  13. Unger T., Mietz J. A., Scheffner M., Yee C. L. & Howley P. M. (1993). Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression.  Molecular and Cellular Biology. 1993 Sept , 13 (9):5186-94.
  14. Mietz J. A., Unger T., Huibregtse J. M. & Howley P. M. (1992). The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.  EMBO Journal. 1992 Dec , 11 (13):5013-20.
  15. Unger T., Nau M. M., Segal S. & Minna J. D. (1992). p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.  EMBO Journal. 1992 Apr , 11 (4):1383-90.
  16. Unger T. & Shaul Y. (1990). The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element.  EMBO Journal. 1990 Jun 1 , 9 (6):1889-1895.
  17. MOCK B., Givol D., DHOOSTELAERE L., HUPPI K., SELDIN M., GURFINKEL N., Unger T., POTTER M. & MUSHINSKI J. (1988). Mapping of the bcl-2 oncogene on mouse chromosome 1.  Cytogenetics and Cell Genetics. 1988, 47 (1-2):11-15.
  18. Gurfinkel N., Unger T., Givol D. & Mushinski J. F. (1987). Expression of the bcl2 gene in mouse B lymphocytic cell lines is differentiation stage specific.  European Journal of Immunology. 1987, 17 (4):567-570.
  19. KATZIR N., RECHAVI G., COHEN J., Unger T., SIMONI F., SEGAL S., Cohen D. & Givol D. (1985). 'Retroposon' insertion into the cellular oncogene c-myc in canine transmissible venereal tumor.  Proceedings of the National Academy of Sciences of the United States of America. 1985, 82 (4):1054-1058.
  20. COHEN J., Unger T., RECHAVI G., Canaani E. & Givol D. (1983). Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas.  Nature. 1983, 306 (5945):797-799.